Ferritinophagy and ferroptosis in the management of metabolic diseases

Amir Ajoolabady; Hami Aslkhodapasandhokmabad; Peter Libby; Jaakko Tuomeilehto; Gregory Y.H. Lip; Josef Penninger; Des. R. Richarrdson; Daoli Tang; Hao Zhou; Shuyi Wang; Daniel . J. Kionsky; Guido Guido Kroemer; Jun Ren

Related publications

Article2021

Ferritinophagy and ferroptosis in the management of metabolic diseases

Amir Ajoolabady, Hamid Aslkhodapasandhokmabad, Peter Libby, Jaakko Tuomilehto, Gregory Y.H. Lip, Josef Penninger, Des R. Richardson, Daolin Tang, Hao Zhou, Shuyi Wang, Daniel J. Klionsky, Guido Guido Kroemer, Jun Ren

Article2021

Ferritinophagy and ferroptosis in the management of metabolic diseases

Amir Ajoolabady, Hami Aslkhodapasandhokmabad, Peter Libby, Jaakko Tuomeilehto, Gregory Y.H. Lip, Josef Penninger, Des. R. Richarrdson, Daoli Tang, Hao Zhou, Shuyi Wang, Daniel . J. Kionsky, Guido Guido Kroemer, Jun Ren

Article2022

The lipid flippase SLC47A1 blocks metabolic vulnerability to ferroptosis

Zhi Lin, Jiao Liu, Fei Long, Rui Kang, Guido Guido Kroemer, Daolin Tang, Minghua Yang

Article2013

Probiotics in the Management of Lung Diseases

Esmaeil Mortaz, Ian M. Adcock, Gert Folkerts, Peter J Barnes, Arjan P. Vos, Johan Garssen

Article2017

Why should neuroscientists worry about iron? The emerging role of ferroptosis in the pathophysiology of neuroprogressive diseases

Gerwyn Morris, Michael Berk, André F. Carvalho, Michael Maes, Adam J. Walker, Basant K. Puri

Ferritinophagy and ferroptosis in the management of metabolic diseases

Discussion(0)

Related publications

Ferritinophagy and ferroptosis in the management of metabolic diseases

Ferritinophagy and ferroptosis in the management of metabolic diseases

The lipid flippase SLC47A1 blocks metabolic vulnerability to ferroptosis

Probiotics in the Management of Lung Diseases

Why should neuroscientists worry about iron? The emerging role of ferroptosis in the pathophysiology of neuroprogressive diseases